Dr. Reddy's Laboratories LimitedRDYNYSE
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank43
5Y CAGR-11.2%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
-11.2%/yr
Long-term compound
Percentile
P43
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 2.19% |
| 2024 | -22.83% |
| 2023 | 109.46% |
| 2022 | -21.27% |
| 2021 | 19.64% |
| 2020 | 3.96% |
| 2019 | 59.21% |
| 2018 | -16.19% |
| 2017 | -47.84% |
| 2016 | 64.77% |